Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Foreword

Foreword Dispute Resolution Provisions in Life Sciences Agreements Mary E. Bartkus I. Introduction This paper surveys the dispute resolution provisions of 15 life sciences re- search and development collaboration and license agreements that are non- confidential exhibits to reports filed with the United States Securities and Exchange Commission during the first seven months of 2020 (the “Agree- ments”). Part II provides an overview of the Agreements, including the governance provisions. Part III reviews the dispute resolution provisions, and describes the disputes the parties have agreed to submit to internal res- olution procedures, the disputes they have agreed to exclude from any form of external resolution, and the disputes they have agreed to submit to expert determination, mediation, arbitration, or litigation, or some combination of these procedures. Part IV describes the parties’ approaches to the substan- tive law governing their disputes. For disputes the parties have agreed to submit to arbitration, Part V describes the arbitration agreements, focusing on scope, choice of seat, and arbitrator selection. Finally, Part VI concludes that the complex dispute resolution provisions in these Agreements can lead to litigation on scope and exercise of decision rights, jurisdictional disputes, parallel arbitration and litigation proceedings, and inconsistent judgments. II. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Dispute Resolution Journal Kluwer Law International

Foreword

Dispute Resolution Journal , Volume 75 (2): 1 – Apr 1, 2020

Loading next page...
 
/lp/kluwer-law-international/foreword-6ML4QUfQ6w
Publisher
Kluwer Law International
Copyright
Copyright © 2020 Kluwer Law International BV, The Netherlands
ISSN
1074-8105
Publisher site
See Article on Publisher Site

Abstract

Dispute Resolution Provisions in Life Sciences Agreements Mary E. Bartkus I. Introduction This paper surveys the dispute resolution provisions of 15 life sciences re- search and development collaboration and license agreements that are non- confidential exhibits to reports filed with the United States Securities and Exchange Commission during the first seven months of 2020 (the “Agree- ments”). Part II provides an overview of the Agreements, including the governance provisions. Part III reviews the dispute resolution provisions, and describes the disputes the parties have agreed to submit to internal res- olution procedures, the disputes they have agreed to exclude from any form of external resolution, and the disputes they have agreed to submit to expert determination, mediation, arbitration, or litigation, or some combination of these procedures. Part IV describes the parties’ approaches to the substan- tive law governing their disputes. For disputes the parties have agreed to submit to arbitration, Part V describes the arbitration agreements, focusing on scope, choice of seat, and arbitrator selection. Finally, Part VI concludes that the complex dispute resolution provisions in these Agreements can lead to litigation on scope and exercise of decision rights, jurisdictional disputes, parallel arbitration and litigation proceedings, and inconsistent judgments. II.

Journal

Dispute Resolution JournalKluwer Law International

Published: Apr 1, 2020

There are no references for this article.